ArticleScientific reports2023

Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.

Annarita Fanizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.